drugset / Trial / NCT00920387

Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

NCT00920387 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will find out whether psychotherapy combined with lysergic acid diethylamide (LSD) is safe and is helpful in people who are anxious because they have a potentially fatal disease. The study will measure anxiety and quality of life before and after people have two sessions with either full or active placebo dose of LSD. They expect LSD-assisted psychotherapy to reduce anxiety and improve quality of life.

Timeline

Start
2008-02
Primary completion
2011-04-14
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject LSD Unknown 20 ug Oral
Subject LSD Unknown 200 ug Oral

Indications